Zhang Wei, Wang Jia-Lun, Tang Li-Ying, Zhan Zhi-Lai, Peng Hua-Sheng, Yang Hong-Jun
Insititute of Chinese Materia Medica,China Academy of Chinese Medical Sciences Beijing 100700,China.
National Resource Center for Chinese Materia Medica,China Academy of Chinese Medical Sciences Beijing 100700,China.
Zhongguo Zhong Yao Za Zhi. 2019 Dec;44(24):5503-5507. doi: 10.19540/j.cnki.cjcmm.20191009.102.
To clarify the change and development of original plants of " Manjingzi"( Viticis Fructus),a traditional Chinese medicine,we investigated Vitex species on the ancient Chinese herbal texts. The study concluded that the Vitex trifolia and V. trifolia var.simplicifolia included in the Chinese Pharmacopoeia( 2015 edition) are only two sources of ancient medicinal Viticis Fructus. There are many sources of vines used in ancient times,which are not fixed and unified. The early use of Viticis Fructus is likely to be the V. quinate var. quinata,V. negundo var. cannabifolia and V. negundo var. negundo. From the Tang Dynasty,the use of V. trifolia var. simplicifolia has been appeared. Until Li Shizhen of the Ming Dynasty,the V. trifolia has been used as a source of medicine for the Viticis Fructus,but even so,the source of medicinal plants of Viticis Fructus has not been unified. We suggested V. trifolia var. simplicifolia be used as mainly species for " Manjingzi" due to its widely used in ancient China.
为阐明中药“蔓荆子”原植物的变迁与发展，我们对古代本草典籍中的牡荆属植物进行了考察。研究得出，《中国药典》（2015年版）收载的单叶蔓荆和蔓荆是古代药用蔓荆子仅有的两个来源。古代蔓荆子的用药来源众多，并不固定统一。早期使用的蔓荆子可能为尖叶牡荆、牡荆叶和黄荆。从唐代起，开始出现单叶蔓荆的药用记载。直至明代李时珍时期，蔓荆才作为蔓荆子的药用来源，但即便如此，蔓荆子的药用植物来源仍未统一。鉴于单叶蔓荆在我国古代应用广泛，建议将其作为“蔓荆子”的主要基原物种。
